Literature DB >> 656267

Outcome of pregnancy in mothers given bromocriptine.

R W Griffith, I Turkalj, P Braun.   

Abstract

1 Information has been obtained on the outcome of 448 completed pregnancies in mothers who had been given bromocriptine at some stage in the early weeks of pregnancy. 2 The frequencies of spontaneous abortions, twin pregnancies and malformations have been compared with those reported for 'normal' populations. 3 Based on this limited material, we conclude that the use of bromocriptine to restore fertility in hyperprolactinaemic women is not associated with an increased risk of abortion, multiple pregnancy or the occurrence of malformations in the infants.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656267      PMCID: PMC1429261          DOI: 10.1111/j.1365-2125.1978.tb01629.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Management of hyperprolactinaemic amenorrhoea.

Authors:  S Franks; H S Jacobs; M G Hull; S J Steele; J D Nabarro
Journal:  Br J Obstet Gynaecol       Date:  1977-04

2.  Induction of ovulation with clompiphene citrate.

Authors:  N Kase
Journal:  Clin Obstet Gynecol       Date:  1973-09       Impact factor: 2.190

3.  Use of human menopausal gonadotropin for the induction of ovulation.

Authors:  L R Spadoni; D W Cox; D C Smith
Journal:  Am J Obstet Gynecol       Date:  1974-12-01       Impact factor: 8.661

4.  Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy.

Authors:  C R Thompson; L M Hansen
Journal:  Fertil Steril       Date:  1970-12       Impact factor: 7.329

5.  Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy.

Authors:  M Hack; M Brish; D M Serr; V Insler; B Lunenfeld
Journal:  JAMA       Date:  1970-02-02       Impact factor: 56.272

Review 6.  Environmental teratogens of man.

Authors:  R W Smithells
Journal:  Br Med Bull       Date:  1976-01       Impact factor: 4.291

7.  Cervical incompetence and premature delivery after bromocriptine therapy for infertility.

Authors:  O Jürgensen; H D Taubert
Journal:  Lancet       Date:  1977-07-23       Impact factor: 79.321

8.  Bromocriptine treatment of female infertility: report of 13 pregnancies.

Authors:  M O Thorner; G M Besser; A Jones; J Dacie; A E Jones
Journal:  Br Med J       Date:  1975-12-20

9.  Outcome of pregnancy after clomiphene therapy.

Authors:  M Ahlgren; B Källén; G Rannevik
Journal:  Acta Obstet Gynecol Scand       Date:  1976       Impact factor: 3.636

  9 in total
  13 in total

1.  Prolactinoma: a question of rational treatment.

Authors:  C R Edwards; C M Feek
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

2.  Trends in the management of prolactinomas.

Authors: 
Journal:  Br Med J       Date:  1980-08-02

3.  The use of bromocriptine in the management of non-puerperal mastitis.

Authors:  F Peters; M Hilgarth; M Breckwoldt
Journal:  Arch Gynecol       Date:  1982

4.  [Hyperprolactinemia and sterility].

Authors:  H K Rjosk; R Fahlbusch; K von Werder
Journal:  Arch Gynecol       Date:  1979-07-20

Review 5.  Pituitary microadenomas: diagnostic and therapeutic trends.

Authors:  E M Grimes
Journal:  J Natl Med Assoc       Date:  1984-10       Impact factor: 1.798

Review 6.  Bromocriptine in the treatment of hypogonadism and male impotence.

Authors:  C M March
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 7.  Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Authors:  S Franks
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

8.  Teratogenicity of bromocryptine in pregnant rats.

Authors:  D Weinstein; D Ben-Amitay; J G Schenker; A Ornoy; A A Hochberg; R Folman
Journal:  Arch Gynecol       Date:  1982

9.  Pituitary tumours during pregnancy in mothers treated with bromocriptine.

Authors:  R W Griffith; I Turkalj; P Braun
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 10.  Adverse effects of antiparkinsonian drugs.

Authors:  J D Parkes
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.